We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Constellation Healthcare Technologies | LSE:CHT | London | Ordinary Share | CMN SHS USD0.0001 (DI/REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 216.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/9/2016 08:25 | I'm adding Rivaldo...... | santangello | |
15/9/2016 08:23 | Encouraging to see a £2.5k buy cause a tick up. | rivaldo | |
14/9/2016 19:50 | Some chunky trades showing up after the bell as well Riv. | deltrotter | |
14/9/2016 14:07 | Very interesting trade just reported - a £28,000 buy at 175p. That's a full 5p above the published offer price. Certainly keen. | rivaldo | |
14/9/2016 09:06 | I really recommend reading CHT's full Annual Report - the Chairman's Review, Strategic Review and Key Strengths sections aren't shown in the RNS version and are most informative: I particularly like this from the Key Strengths: "Recurring revenue base – the Group’s RCM division typically enters into customer contracts which have two to five year terms that auto-renew for additional one year periods thus providing some visibility of future revenues. The Group’s RCM division generated revenues for the year ended 31 December 2015 of approximately $50.1m (representing approximately 65.4% of Group revenue). In addition, the Group’s PM division provides business, administrative and practice management services to physicians under a 40-year management agreement. The PM division has provided a base of stable and growing revenues historically." | rivaldo | |
14/9/2016 08:19 | L2 making more sense this morning. As expected some resistance showing at 170p, but that can quickly change in very illiqiud stocks | pj 1 | |
13/9/2016 12:49 | Yes, L2 has that strange anomoly where all the 3 MM's are on the bid at 160 and all 3 on the offer at 170p. | pj 1 | |
13/9/2016 12:27 | Given buying now at the full 170p offer, I'm assuming the trades at 165p are sells, which is pretty encouraging. | rivaldo | |
13/9/2016 11:30 | I hold these in my SIPP and wanted to add in my ISA, however infuriatingly Selftrade dont permit allow them to be bought | adamb1978 | |
13/9/2016 09:55 | Ha ha - spectacular. It should be throwing off buckets of cash once their business model gets into full swing. | deltrotter | |
13/9/2016 09:10 | Del, Finncap forecast $27.4m of free cash flow next year (2017) in their report from Jan'16. Pretty satisfactory :o)) | rivaldo | |
13/9/2016 08:28 | Repost from me: deltrotter 6 Sep '16 - 09:07 - 566 of 587 0 0 Edit Gee guys, I can't see past this: "free cash flow has moved from a $4m outflow to an $11m inflow" So, what will it be for the next 12 months?? | deltrotter | |
13/9/2016 08:27 | Yep, breaking upwards now. This morning's buyer at 165p has already been warded with a rise. Given the lack of free float, and the apparent clearance of the seller, things could get extremely interesting here with any further demand as Santangello says. We could see 200p within a few days for starters with a bit of buying and a little press interest. | rivaldo | |
13/9/2016 08:08 | Moving on up :)) | battlebus2 | |
13/9/2016 07:41 | After a period of consolidation, these look to be breaking out ?With the stock being so tightly held, they could move decidily higher quite quickly.... | santangello | |
12/9/2016 17:14 | Yes and the restrictions on dealing puts a lot off. | battlebus2 | |
12/9/2016 17:09 | Im not sure BB2 as i dont follow it that closely but note 3 increases to eps forecasts in last 12 months which will have helped. However. the 'momentum' score is only 58 so if volume/momentum does kick in then the overall score should rise more. Maybe Parmar should relinquish the CEO role and move to another position. I'm sure we would all sleep easier. | pj 1 | |
12/9/2016 17:01 | Excellent-bought in after results-looked to me way to cheap and believed that the company is one in the right place at the right time and could grow and grow in a wide open market. I also think that the profits could grow faster than turnover as they benefit from economies of scale. I often find that with some companies that issue great results that the share price hardly moves for a week or two, then starts rising. I think this is due to Funds taking time to to analyse data thoroughly before buying, which can then give rise to a significant share price increase. Time will tell. | loobrush | |
12/9/2016 16:53 | That's quite a jump, what's changed really since then?? | battlebus2 | |
12/9/2016 16:49 | Just a comment. In July CHT had a stockopedia rank of 46, which has now increased to 84. | pj 1 | |
12/9/2016 16:38 | I think Gervais Williams has added a little more credibility here and from previous experience his timing usually signals new to come. Let's see what the next few days bring. Trading at a crazy discount so might see a sharp rise to £2. DYOR etc | battlebus2 | |
12/9/2016 16:32 | yes, thanks Guys, definitely the exception to the Rule...! :-) | pj 1 | |
12/9/2016 16:28 | Well this is very welcome indeed, you've timed your return perfectly PJ.. | battlebus2 | |
12/9/2016 16:06 | New recent highs now (and welcome PJ1). | rivaldo | |
12/9/2016 15:05 | Good to see you back here PJ....... | battlebus2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions